•$C4 Therapeutics (CCCC.US)$+1.2% (received a Study May Proceed LetterfromtheFDAto begin a Phase 1/2 trial for CFT1946 a treatmentofBRAF-V600 mutantsolidtumors)
•$Agree Realty Corp (ADC.US)$-3.3% (prices 5 mln shares of its common stock at a public offering price of $66.85 per share in connection with the forward sale agreements)
•$Volta (VLTA.US)$-3.2% (announces organizational realignment; to cut 10% of employees; guides Q3 revs below consensus; withdraws FY22 revenue guidance)
•$Bilibili (BILI.US)$-1.4% (submitted with the Hong Kong Stock Exchange an announcement of voluntary conversion to dual-primary listing on The Main Board of The Stock Exchange of Hong Kong Limited - will be effective Oct 3)
Analyst comments:
•$Olaplex (OLPX.US)$-3.5% (downgraded to Neutral from Overweight at Piper Sandler)